RA Capital Healthcare Fund LP's Net Worth

$2.37 Billion

Estimate Recalculated Feb 23, 2024 08:58PM EST

Who is RA Capital Healthcare Fund LP?

RA Capital Healthcare Fund LP has an estimated net worth of $2.37 Billion. This is based on reported shares across multiple companies, which include AN2 Therapeutics, Inc., RHYTHM PHARMACEUTICALS, INC., Vaxcyte, Inc., Dicerna Pharmaceuticals Inc, Eidos Therapeutics, Inc., iTeos Therapeutics, Inc., Mineralys Therapeutics, Inc., Cytek Biosciences, Inc., DICE Therapeutics, Inc., SANGAMO BIOSCIENCES INC, Icosavax, Inc., Tyra Biosciences, Inc., MIRAGEN THERAPEUTICS, INC., RxSight, Inc., Phathom Pharmaceuticals, Inc., TG THERAPEUTICS, INC., Eiger BioPharmaceuticals, Inc., Eliem Therapeutics, Inc., KalVista Pharmaceuticals, Inc., Vor Biopharma Inc., Verastem, Inc., Janux Therapeutics, Inc., Aerovate Therapeutics, Inc., Forma Therapeutics Holdings, Inc., Therapeutics Acquisition Corp., G1 Therapeutics, Inc., ARVINAS INC., Synthorx, Inc., CURIS INC, Acumen Pharmaceuticals, Inc., 89bio, Inc., Solid Biosciences Inc., Aclaris Therapeutics, Inc., Iterum Therapeutics plc, Kala Pharmaceuticals, Inc., Orchard Therapeutics plc, Satsuma Pharmaceuticals, Inc., Akouos, Inc., Wave Life Sciences Ltd., Werewolf Therapeutics, Inc., Enliven Therapeutics, Inc., Ra Pharmaceuticals, Inc., Nkarta, Inc., Fulcrum Therapeutics, Inc., scPharmaceuticals Inc., ACHILLION PHARMACEUTICALS INC, ARS Pharmaceuticals, Inc., PepGen Inc., Black Diamond Therapeutics, Inc., DERMA SCIENCES, INC., SEQUENOM INC, BIOSPECIFICS TECHNOLOGIES CORP, Acrivon Therapeutics, Inc., ARADIGM CORP, and LIPID SCIENCES INC/.

SEC CIK

RA Capital Healthcare Fund LP's CIK is 0001315082

Past Insider Trading and Trends

2008 was RA Capital Healthcare Fund LP's most active year for acquiring shares with 337 total transactions. RA Capital Healthcare Fund LP's most active month to acquire stocks was the month of May. 2014 was RA Capital Healthcare Fund LP's most active year for disposing of shares, totalling 164 transactions. RA Capital Healthcare Fund LP's most active month to dispose stocks was the month of August. 2020 saw RA Capital Healthcare Fund LP paying a total of $210,424,220.72 for 22,170,586 shares, this is the most they've acquired in one year. In 2020 RA Capital Healthcare Fund LP cashed out on 81,644,410 shares for a total of $1,599,128,787.86, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

AN2 Therapeutics, Inc. (ANTX) Snapshot price: $20.99

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+52.94%
1.78M
$9.00
$16,000,002.00
5.14M
Aug 18
Form 4
+0.03%
1.91K
$7.74
$14,330.32
7.55M
Aug 3 - Aug 4
Form 4
+0.62%
23.22K
$7.78
$180,674.69
3.77M
Jul 26 - Jul 27
Form 4
+0.01%
302
$7.99
$2,412.98
3.75M
Jun 21
Form 4
+2.22%
81.42K
$7.95
$647,401.86
3.75M
Jun 13 - Jun 14
Form 4
3.67M
$15.00
3.67M
Mar 29
Form 3
0
0
No matching records found

RHYTHM PHARMACEUTICALS, INC. (RYTM) Snapshot price: $47.85

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-5.19%
-238.54K
$29.47
-$7,029,652.62
4.36M
Dec 2 - Dec 3
Form 4
-2.50%
-131.58K
$22.06
-$2,902,517.12
5.14M
Jun 30 - Jul 2
Form 4
-2.77%
-150.32K
$23.05
-$3,465,614.60
5.27M
Jun 25 - Jun 29
Form 3
0
0
No matching records found

Vaxcyte, Inc. (PCVX) Snapshot price: $73.885

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-5.05%
-266.26K
$50.78
-$13,521,592.46
5M
Oct 7 - Oct 8
Form 4
-3.94%
-221.33K
$49.81
-$11,245,562.88
5.39M
Sep 29 - Oct 1
Form 3
0
0
No matching records found

Dicerna Pharmaceuticals Inc No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+108.93%
2.65M
5.07M
Dec 18
Form 4
0
0
Apr 11
Form 4
0
0
Apr 16
Form 4
2.43M
$15.00
2.43M
Feb 4
Form 3
0
0
No matching records found

Eidos Therapeutics, Inc. No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
2.16M
$17.00
2.16M
Jun 22
Form 3
0
0
No matching records found